Search
for
Sort by
Research 511–540 of 1000+
- Patient-Controlled Expansion: Applying a New Technique to Breast Reconstruction
- Minoxidil for Endocrine Therapy–Induced Alopecia in Women With Breast Cancer—Saint Agatha’s Blessing?
- Efficacy and Safety of Cinobufacin Combined with Chemotherapy for Advanced Breast Cancer: A Systematic Review and Meta‐Analysis
- Evaluation of trichodynia (hair pain) during chemotherapy or tamoxifen treatment in breast cancer patients
- Transcription Regulation and Protein Subcellular Localization of the Truncated Basic Hair Keratin hHb1-ΔN in Human Breast Cancer Cells
- Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview
- Diagnostic Value of VDR in Bone Metastasis and Prognosis of Patients with Breast Cancer and Expression Correlation between Vitamin D Receptor and Hairless Protein
- Therapeutic Effect of Superficial Scalp Hypothermia on Chemotherapy-Induced Alopecia in Breast Cancer Survivors
- Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients
- Taxane-induced alopecia: A historical review of patients with ovarian or breast cancer treated with with paclitaxel, docetaxel or paclitaxel poliglumex
- Improving preparation for scalp cooling: Learning from women undergoing chemotherapy for early‐stage breast cancer—The COOL study
- CDK4/6 plus aromatase inhibitor-induced alopecia in breast cancer patients.
- Alopecia areata and myasthenia gravis presenting as paraneoplastic phenomena of breast cancer
- Ki-67 Levels and Their Association With Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Prospective Observational Study
- A Quantitative Measurement Method for Nuclear-Pleomorphism Scoring in Breast Cancer
- The Potential of Ultrasound Technology and Chemotherapy Carriers in Breast Cancer Treatment
- Abstract P3-09-15: Permanent chemotherapy induced alopecia in early breast cancer patients after (neo)adjuvant chemotherapy: Long term follow up
- Outcome and clinical–biological characteristics of patients with advanced breast cancer undergoing removal of ovarian/pelvic metastases
- Assessment of long-term alopecia after adjuvant taxane therapy for early breast cancer: a cross-sectional survey
- Approaches to management of endocrine therapy–induced alopecia in breast cancer patients
- Scalp hypothermia for the prevention of chemotherapy-induced alopecia in breast cancer
- Assessment of hair loss and skin changes during treatment in Asian breast cancer patients: A prospective cohort study
- Bilateral periorbital swelling as the presenting manifestation of recurrent breast carcinoma
- Study of alpha mangostin as a chemoprotective agent for breast cancer via activation of the p53 pathway
- Patient-reported Outcomes of Adverse Events After Perioperative Chemotherapy for Breast Cancer: A Prospective Observational Study
- Spiritual well-being and quality of life among newly diagnosed Palestinian women with breast cancer: a prospective study
- Anlotinib or Bevacizumab Combined with Taxane/Capecitabine for the Second-Line or Subsequent Treatment of HER-2 Negative Metastatic Breast Cancer: A Retrospective Cohort Study
- Patient-reported outcomes following various incision techniques in breast reconstruction: an observational cohort study in China
- Patient-reported outcomes of adverse events after perioperative chemotherapy for breast cancer: A prospective observational study
- SAT-724 Persistently Elevated Alkaline Phosphatase in an Older Woman with a History of Breast Cancer